6.85
0.44%
-0.03
Immatics N V Aktie (IMTX) Neueste Nachrichten
Immatics (NASDAQ:IMTX) Hits New 12-Month LowWhat's Next? - MarketBeat
Immatics (NASDAQ:IMTX) Sees Significant Increase in Short Interest - MarketBeat
(IMTX) Technical Pivots with Risk Controls - Stock Traders Daily
Immatics (NASDAQ:IMTX) Trading Down 4.2%What's Next? - MarketBeat
Immatics Faces Termination of Key Collaboration with Bristol Myers Squibb - TipRanks
Immatics (NASDAQ:IMTX) Shares Bought by Frazier Life Sciences Management L.P. - MarketBeat
Wellington Management Group LLP Has $110.46 Million Stock Holdings in Immatics (NASDAQ:IMTX) - MarketBeat
The Manufacturers Life Insurance Company Grows Stock Position in Immatics (NASDAQ:IMTX) - Defense World
Reviewing bluebird bio (NASDAQ:BLUE) and Immatics (NASDAQ:IMTX) - Defense World
Why Is Immatics N.V. (IMTX) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds? - Yahoo Finance
Walleye Capital LLC Lowers Stock Holdings in Immatics (NASDAQ:IMTX) - MarketBeat
Braidwell LP Makes New $18.80 Million Investment in Immatics (NASDAQ:IMTX) - MarketBeat
Immatics NV (FRA:4A3) EBITDA per Share : €-0.40 (TTM As of Sep. 2024) - GuruFocus.com
Vestal Point Capital LP Grows Stock Holdings in Immatics (NASDAQ:IMTX) - MarketBeat
Immatics (NASDAQ:IMTX) Upgraded by The Goldman Sachs Group to "Strong-Buy" Rating - MarketBeat
Exscientia (NASDAQ:EXAI) & Immatics (NASDAQ:IMTX) Head to Head Comparison - Defense World
Immatics N.V. Reports Strong Q3 2024 Progress and Financials - TipRanks
(IMTX) Investment Analysis - Stock Traders Daily
Cantor Fitzgerald Raises Earnings Estimates for Immatics - Defense World
Immatics FY2024 EPS Forecast Boosted by Cantor Fitzgerald - MarketBeat
Analysts Set Expectations for Immatics FY2024 Earnings - Defense World
FY2024 EPS Estimates for Immatics Increased by Analyst - MarketBeat
Immatics (NASDAQ:IMTX) Reaches New 1-Year Low Following Analyst Downgrade - Defense World
Bank of America Has Lowered Expectations for Immatics (NASDAQ:IMTX) Stock Price - Defense World
Immatics N.V. (NASDAQ:IMTX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates - Yahoo Finance
10 Best German Stocks To Buy Now - Insider Monkey
Is Immatics N.V. (IMTX) the Best German Stock to Buy Now? - Insider Monkey
Bank of America Issues Pessimistic Forecast for Immatics (NASDAQ:IMTX) Stock Price - MarketBeat
Immatics Sees Revenue Surge Despite R&D Expenses - Yahoo Finance
Immatics: Q3 Earnings Snapshot - Milford Mirror
Immatics NV earnings beat by €0.14, revenue topped estimates - Investing.com UK
What Makes Immatics (IMTX) a New Buy Stock - Yahoo Finance
Immatics N.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Immatics reports Q3 EPS (EUR 0.11) vs. (EUR 0.32) last year - TipRanks
Immatics (IMTX) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Immatics announces clinical data on TCER IMA402 targeting PRAME - TipRanks
Immatics sees cash runway into 2H27 - TipRanks
Immatics Announces Third Quarter 2024 Financial Results, - GlobeNewswire
Immatics Reports Early Success in Melanoma Treatment, Plans Phase 3 Trial as Cash Position Tops $699M | IMTX Stock News - StockTitan
T. Rowe Price Investment Management, Inc. Reduces Stake in Immatics NV - GuruFocus.com
Immatics (NASDAQ:IMTX) Reaches New 52-Week LowShould You Sell? - MarketBeat
When the Price of (IMTX) Talks, People Listen - Stock Traders Daily
Immatics N.V. Warrants (IMTXW) SEC Filing Summary - Quartzy
IMTX (Immatics NV) FCF Yield % : -4.41 (As of Nov. 11, 2024) - GuruFocus.com
Immatics Announces Multiple Presentations at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) on TCR-T Therapy Candidates Targeting PRAME - 新浪香港
Immatics Unveils Promising TCR-T Therapy Developments - TipRanks
Immatics Announces Multiple Presentations at the 39th - GlobeNewswire
Wellington Management Group LLP Increases Stake in Immatics NV - GuruFocus.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):